Oral GLP-1 Pill For Weight Loss Shows Promise, But Challenges Remain

The pharmaceutical giant Eli Lilly announced last week that its investigational drug, orforglipron, proved effective in a third late-stage clinical trial. The once-daily pill helps patients with obesity and type 2 diabetes lose weight and lower their blood sugar levels. Still, challenges remain, which include relatively high discontinuation rates that appear to be the result of…